{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:08:56Z","timestamp":1783811336453,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02228-7","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:45:51Z","timestamp":1783748751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between diabetes and elevated circulating advanced oxidation protein products: a comprehensive systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Muhammad Shahid","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Faiyaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Zahid Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Ud-Din","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Devanathadesikan","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Ali Mohamed","family":"Abdelgawwad El-Sehrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"4","key":"2228_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5897\/JPAP2013.0001","volume":"4","author":"J Ozougwu","year":"2013","unstructured":"Ozougwu J, Obimba K, Belonwu C, Unakalamba C. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4(4):46\u201357.","journal-title":"J Physiol Pathophysiol"},{"issue":"Supplement1","key":"2228_CR2","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"AD Association","year":"2020","unstructured":"Association AD. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142020. Diabetes Care. 2020;43(Supplement1):S14\u201331.","journal-title":"Diabetes Care"},{"issue":"3","key":"2228_CR3","doi-asserted-by":"publisher","first-page":"S747","DOI":"10.1093\/ajcn\/59.3.747S","volume":"59","author":"JC Miller","year":"1994","unstructured":"Miller JC. Importance of glycemic index in diabetes. Am J Clin Nutr. 1994;59(3):S747\u201352.","journal-title":"Am J Clin Nutr"},{"key":"2228_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cyto.2019.05.007","volume":"120","author":"F Heidari","year":"2019","unstructured":"Heidari F, Rabizadeh S, Mansournia MA, Mirmiranpoor H, Salehi SS, Akhavan S, et al. Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes. Cytokine. 2019;120:186\u201390.","journal-title":"Cytokine"},{"key":"2228_CR5","doi-asserted-by":"publisher","first-page":"118422","DOI":"10.1016\/j.lfs.2020.118422","volume":"260","author":"F Heidari","year":"2020","unstructured":"Heidari F, Rabizadeh S, Rajab A, Heidari F, Mouodi M, Mirmiranpour H, et al. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes. Life Sci. 2020;260:118422.","journal-title":"Life Sci"},{"issue":"6","key":"2228_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.33549\/physiolres.930234","volume":"51","author":"M Kalousov\u00e1","year":"2002","unstructured":"Kalousov\u00e1 M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res. 2002;51(6):597\u2013604.","journal-title":"Physiol Res"},{"key":"2228_CR7","doi-asserted-by":"publisher","first-page":"4975264","DOI":"10.1155\/2017\/4975264","volume":"2017","author":"B Gryszczy\u0144ska","year":"2017","unstructured":"Gryszczy\u0144ska B, Formanowicz D, Budzy\u0144 M, Wanic-Kossowska M, Pawliczak E, Formanowicz P, et al. Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases. Biomed Res Int. 2017;2017:4975264.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2228_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12872-021-02451-2","volume":"22","author":"Z Bagyura","year":"2022","unstructured":"Bagyura Z, Tak\u00e1cs A, Kiss L, D\u00f3sa E, Vadas R, Nguyen TD, et al. Level of advanced oxidation protein products is associated with subclinical atherosclerosis. BMC Cardiovasc Disord. 2022;22(1):5.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"2228_CR9","first-page":"342","volume":"30","author":"S Collado","year":"2010","unstructured":"Collado S, Coll E, Deulofeu R, Guerrero L, Pons M, Cruzado JM, et al. [Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors]. Nefrologia: publicacion oficial de la Sociedad Esp Nefrologia. 2010;30(3):342\u20138.","journal-title":"Nefrologia: publicacion oficial de la Sociedad Esp Nefrologia"},{"issue":"1","key":"2228_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.ajkd.2004.09.011","volume":"45","author":"B Descamps-Latscha","year":"2005","unstructured":"Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, et al. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J kidney diseases: official J Natl Kidney Foundation. 2005;45(1):39\u201347.","journal-title":"Am J kidney diseases: official J Natl Kidney Foundation"},{"issue":"12","key":"2228_CR11","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1111\/apa.14372","volume":"107","author":"I Koborov\u00e1","year":"1992","unstructured":"Koborov\u00e1 I, Gureck\u00e1 R, Csongov\u00e1 M, \u0160ebek J, \u0160ebekov\u00e1 K. Plasma markers of oxidative status were associated with increasing continuous cardiometabolic risk scores in healthy students aged 16\u201320 years without central obesity. Acta paediatrica (Oslo, Norway\u202f: 1992). 1992;107(12):2137\u201345.","journal-title":"Acta paediatrica (Oslo, Norway : 1992)"},{"issue":"2","key":"2228_CR12","doi-asserted-by":"publisher","first-page":"e0171561","DOI":"10.1371\/journal.pone.0171561","volume":"12","author":"M Rasool","year":"2017","unstructured":"Rasool M, Ashraf MA, Malik A, Waquar S, Khan SA, Qazi MH, et al. Comparative study of extrapolative factors linked with oxidative injury and anti-inflammatory status in chronic kidney disease patients experiencing cardiovascular distress. PLoS ONE. 2017;12(2):e0171561.","journal-title":"PLoS ONE"},{"issue":"2","key":"2228_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.sjbs.2018.08.024","volume":"26","author":"M Rasool","year":"2019","unstructured":"Rasool M, Malik A, Butt TT, Ashraf MAB, Rasool R, Zahid A, et al. Implications of advanced oxidation protein products (AOPPs), advanced glycation end products (AGEs) and other biomarkers in the development of cardiovascular diseases. Saudi J Biol Sci. 2019;26(2):334\u20139.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"2228_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/00365513.2015.1092048","volume":"76","author":"JM D\u2019Souza","year":"2016","unstructured":"D\u2019Souza JM, D\u2019Souza RP, Vijin VF, Shetty A, Arunachalam C, Pai VR, et al. High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus. Scand J Clin Lab Investig. 2016;76(1):51\u20137.","journal-title":"Scand J Clin Lab Investig"},{"key":"2228_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jprot.2013.03.034","volume":"92","author":"D Gradinaru","year":"2013","unstructured":"Gradinaru D, Borsa C, Ionescu C, Margina D. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. J Proteom. 2013;92:313\u201322.","journal-title":"J Proteom"},{"issue":"1","key":"2228_CR16","first-page":"21","volume":"105","author":"M Kalousov\u00e1","year":"2004","unstructured":"Kalousov\u00e1 M, Fialov\u00e1 L, Skrha J, Zima T, Soukupov\u00e1 J, Malbohan IM, et al. Oxidative stress, inflammation and autoimmune reaction in type 1 and type 2 diabetes mellitus. Prague Med Rep. 2004;105(1):21\u20138.","journal-title":"Prague Med Rep"},{"issue":"Suppl 1","key":"2228_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00592-009-0128-1","volume":"47","author":"HZ Pan","year":"2010","unstructured":"Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu WH, et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol. 2010;47(Suppl 1):71\u20136.","journal-title":"Acta Diabetol"},{"issue":"3","key":"2228_CR18","doi-asserted-by":"publisher","first-page":"E163","DOI":"10.25011\/cim.v34i3.15189","volume":"34","author":"O Tabak","year":"2011","unstructured":"Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H, et al. Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med Med clinique et experimentale. 2011;34(3):E163\u201371.","journal-title":"Clin Invest Med Med clinique et experimentale"},{"key":"2228_CR19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-123825","author":"D Gradinaru","year":"2018","unstructured":"Gradinaru D, Khaddour H, Margina D, Ungurianu A, Borsa C, Ionescu C, et al. Insulin-leptin axis, cardiometabolic risk and oxidative stress in elderly with metabolic syndrome. Experimental and Clinical Endocrinology & Diabetes. 2018. https:\/\/doi.org\/10.1055\/s-0043-123825.","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"2228_CR20","first-page":"759","volume-title":"Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation","author":"D Venturini","year":"2015","unstructured":"Venturini D, Sim\u00e3o AN, Dichi I. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. Volume 35. New York, NY: Nutrition research; 2015. pp. 759\u201365. 9."},{"issue":"9","key":"2228_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40618-014-0111-8","volume":"37","author":"E Zurawska-P\u0142aksej","year":"2014","unstructured":"Zurawska-P\u0142aksej E, Grzebyk E, Marciniak D, Szyma\u0144ska-Chabowska A, Piwowar A. Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome. J Endocrinol Investig. 2014;37(9):819\u201327.","journal-title":"J Endocrinol Investig"},{"issue":"5\u20136","key":"2228_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1024\/0300-9831\/a000212","volume":"84","author":"A Marques de Mattos","year":"2014","unstructured":"Marques de Mattos A, Afonso Jord\u00e3o A, Abr\u00e3o Cardeal da Costa J, Garcia Chiarello P. Study of Protein Oxidative Stress, Antioxidant Vitamins and Inflammation in Patients Undergoing either Hemodialysis or Peritoneal Dialysis. International journal for vitamin and nutrition research Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. J Int de vitaminologie et de Nutr. 2014;84(5\u20136):261\u20138.","journal-title":"J Int de vitaminologie et de Nutr"},{"issue":"5","key":"2228_CR23","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/S0085-2538(15)48065-2","volume":"60","author":"D Mezzano","year":"2001","unstructured":"Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, et al. Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int. 2001;60(5):1844\u201350.","journal-title":"Kidney Int"},{"issue":"7","key":"2228_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/labinvest.2017.24","volume":"97","author":"M Liang","year":"2017","unstructured":"Liang M, Li A, Lou A, Zhang X, Chen Y, Yang L, et al. Advanced oxidation protein products promote NADPH oxidase-dependent \u03b2-cell destruction and dysfunction through the Bcl-2\/Bax apoptotic pathway. Lab Invest. 2017;97(7):792\u2013805.","journal-title":"Lab Invest"},{"issue":"5","key":"2228_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/1753-0407.12134","volume":"6","author":"M Liang","year":"2014","unstructured":"Liang M, Wang J, Xie C, Yang Y, Tian JW, Xue YM, et al. Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria 2. J diabetes. 2014;6(5):417\u201326.","journal-title":"J diabetes"},{"issue":"4","key":"2228_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3892\/ijmm.2016.2711","volume":"38","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Yang L, Lei L, Chen R, Chen H, Zhang H. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway. Int J Mol Med. 2016;38(4):1161\u20139.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2228_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-016-9377-8","volume":"17","author":"H Ou","year":"2017","unstructured":"Ou H, Huang Z, Mo Z, Xiao J. The characteristics and roles of advanced oxidation protein products in atherosclerosis. Cardiovascular toxicology. 2017;17(1):1\u201312.","journal-title":"Cardiovascular toxicology"},{"issue":"6","key":"2228_CR28","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1159\/000356619","volume":"32","author":"JC Wang","year":"2013","unstructured":"Wang JC, Zhao Y, Chen SJ, Long J, Jia QQ, Zhai JD, et al. AOPPs induce MCP-1 expression by increasing ROS-mediated activation of the NF-\u03baB pathway in rat mesangial cells: inhibition by sesquiterpene lactones. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2013;32(6):1867\u201377.","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"issue":"8","key":"2228_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/10715760802317655","volume":"42","author":"S Leoncini","year":"2008","unstructured":"Leoncini S, Rossi V, Signorini C, Tanganelli I, Comporti M, Ciccoli L. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients. Free radical research. 2008;42(8):716\u201324.","journal-title":"Free radical research"},{"key":"2228_CR30","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"2228_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600324","volume":"61","author":"CE Cho","year":"2017","unstructured":"Cho CE, Taesuwan S, Malysheva OV, Bender E, Tulchinsky NF, Yan J. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 2017;61:1600324.","journal-title":"Mol Nutr Food Res"},{"issue":"16","key":"2228_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168623","volume":"18","author":"R Mamikutty","year":"2021","unstructured":"Mamikutty R, Aly AS, Marhazlinda J. Selecting risk of bias tools for observational studies for a systematic review of anthropometric measurements and dental caries among children. International journal of environmental research and public health. 2021;18(16):8623.","journal-title":"International journal of environmental research and public health"},{"key":"2228_CR33","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"G Wells","year":"2012","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute.; 2012."},{"key":"2228_CR34","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"2228_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d549","volume":"342","author":"RD Riley","year":"2011","unstructured":"Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.","journal-title":"BMJ"},{"key":"2228_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2021.05.015","volume":"171","author":"Y Lu","year":"2021","unstructured":"Lu Y, Jiang H, Zhang H, Li R, Zhang Q, Luo D, et al. Serum oxidized low density lipoprotein serves as a mediator for the inverse relationship between serum d-ribose and cognitive performance in type 2 diabetic patients. Free Radic Biol Med. 2021;171:91\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"2228_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3109\/00365513.2013.846477","volume":"73","author":"GG Korkmaz","year":"2013","unstructured":"Korkmaz GG, Konukoglu D, Kurtulus EM, Irmak H, Bolayirli M, Uzun H. Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients. Scand J Clin Lab Invest. 2013;73(8):641\u20139.","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"2228_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.33549\/physiolres.932672","volume":"63","author":"V Jaku\u0161","year":"2014","unstructured":"Jaku\u0161 V, S\u00e1ndorov\u00e1 E, Kalninov\u00e1 J, Krahulec B. Monitoring of glycation, oxidative stress and inflammation in relation to the occurrence of vascular complications in patients with type 2 diabetes mellitus. Physiol Res. 2014;63(3):297\u2013309.","journal-title":"Physiol Res"},{"key":"2228_CR39","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","volume":"161","author":"V Witko-Sarsat","year":"1998","unstructured":"Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeill\u00e8re-Blandin C, Nguyen AT, Canteloup S. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524\u201332.","journal-title":"J Immunol"},{"issue":"8","key":"2228_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2337\/diacare.23.8.1182","volume":"23","author":"E Matteucci","year":"2000","unstructured":"Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000;23(8):1182\u20136.","journal-title":"Diabetes Care"},{"issue":"3","key":"2228_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2249.2004.02470.x","volume":"136","author":"E Matteucci","year":"2004","unstructured":"Matteucci E, Malvaldi G, Fagnani F, Evangelista I, Giampietro O. Redox status and immune function in type I diabetes families. Clin Exp Immunol. 2004;136(3):549\u201354.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2228_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.phrs.2004.10.012","volume":"51","author":"L Gil-del Valle","year":"2005","unstructured":"Gil-del Valle L, de la Toledo CML, Vilar\u00f3 A, T\u00e1panes N, Otero R. Altered redox status in patients with diabetes mellitus type I. Pharmacol Res. 2005;51(4):375\u201380.","journal-title":"Pharmacol Res"},{"issue":"4","key":"2228_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/bjo.2007.130542","volume":"92","author":"HZ Pan","year":"2008","unstructured":"Pan HZ, Zhang H, Chang D, Li H, Sui H. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol. 2008;92(4):548\u201351.","journal-title":"Br J Ophthalmol"},{"issue":"4\u20135","key":"2228_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.clinbiochem.2009.11.011","volume":"43","author":"KB Pandey","year":"2010","unstructured":"Pandey KB, Mishra N, Rizvi SI. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clin Biochem. 2010;43(4\u20135):508\u201311.","journal-title":"Clin Biochem"},{"issue":"2B","key":"2228_CR45","first-page":"647","volume":"2","author":"K Kar","year":"2014","unstructured":"Kar K, Sinha S. Correlation between advanced oxidation protein products [AOPP] and antioxidant status in Type 2 diabetics in Southern Asian Region. Sch J App Med Sci. 2014;2(2B):647\u201352.","journal-title":"Sch J App Med Sci"},{"issue":"4","key":"2228_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/09674845.2009.11730273","volume":"66","author":"A Piwowar","year":"2009","unstructured":"Piwowar A, Knapik-Kordecka M, Warwas M. Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients. Br J Biomed Sci. 2009;66(4):194\u20139.","journal-title":"Br J Biomed Sci"},{"key":"2228_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55100675","author":"G Conti","year":"2019","unstructured":"Conti G, Caccamo D, Siligato R, Gembillo G, Satta E, Pazzano D, et al. Association of higher advanced oxidation protein products (AOPPs) levels in patients with diabetic and hypertensive nephropathy. Medicina (Kaunas, Lithuania). 2019. https:\/\/doi.org\/10.3390\/medicina55100675.","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"4","key":"2228_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-007-0143-x","volume":"7","author":"H Ko\u00e7ak","year":"2007","unstructured":"Ko\u00e7ak H, Oner-Iyido\u011fan Y, G\u00fcrd\u00f6l F, Oner P, S\u00fczme R, Esin D, et al. Advanced oxidation protein products in obese women: its relation to insulin resistance and resistin. Clin Exp Med. 2007;7(4):173\u20138.","journal-title":"Clin Exp Med"},{"issue":"3","key":"2228_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.numecd.2010.06.002","volume":"22","author":"P Codo\u00f1er-Franch","year":"2012","unstructured":"Codo\u00f1er-Franch P, Tav\u00e1rez-Alonso S, Murria-Estal R, Tortajada-Girb\u00e9s M, Sim\u00f3-Jord\u00e1 R, Alonso-Iglesias E. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children. Nutr Metab Cardiovasc Dis. 2012;22(3):237\u201343.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8\u20139","key":"2228_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.clinbiochem.2011.03.134","volume":"44","author":"A Barsotti","year":"2011","unstructured":"Barsotti A, Fabbi P, Fedele M, Garibaldi S, Balbi M, Bezante GP, et al. Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes. Clin Biochem. 2011;44(8\u20139):605\u201311.","journal-title":"Clin Biochem"},{"issue":"3","key":"2228_CR51","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00628.2016","volume":"314","author":"W Feng","year":"2018","unstructured":"Feng W, Zhang K, Liu Y, Chen J, Cai Q, He W, et al. Advanced oxidation protein products aggravate cardiac remodeling via cardiomyocyte apoptosis in chronic kidney disease. Am J Physiol Heart Circ Physiol. 2018;314(3):H475-h83.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"2228_CR52","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.4049\/jimmunol.161.5.2524","volume":"161","author":"V Witko-Sarsat","year":"1998","unstructured":"Witko-Sarsat V, Friedlander M, Khoa TN, Capeill\u00e8re-Blandin C, Nguyen AT, Canteloup S, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure,. The Journal of immunology. 1998;161(5):2524\u201332.","journal-title":"The Journal of immunology"},{"key":"2228_CR53","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1046\/j.1523-1755.63.s84.47.x","volume":"63","author":"V Witko-Sarsat","year":"2003","unstructured":"Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins? Kidney international. 2003;63:S11\u20134.","journal-title":"Kidney international"},{"issue":"6","key":"2228_CR54","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1159\/000066956","volume":"20","author":"M Kalousov\u00e1","year":"2002","unstructured":"Kalousov\u00e1 M, Zima T, Tesa\u0159 V, Lachmanov\u00e1 J. Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purif. 2002;20(6):531\u20136.","journal-title":"Blood Purif"},{"key":"2228_CR55","doi-asserted-by":"crossref","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G. Small-study effects in meta-analysis. In: Meta-analysis with R. Springer; 2015. p. 107\u201341.","DOI":"10.1007\/978-3-319-21416-0_5"},{"issue":"4","key":"2228_CR56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.numecd.2016.01.006","volume":"26","author":"A Ceriello","year":"2016","unstructured":"Ceriello A, Testa R, Genovese S. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutrition, Metabolism and Cardiovascular Diseases. 2016;26(4):285\u201392.","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"2228_CR57","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1055\/a-1517-6643","volume":"53","author":"M Salem","year":"2021","unstructured":"Salem M, Sallam A-A, Abdel-Aleem E, El-Mesallamy HO. Effect of lisinopril and verapamil on angiopoietin 2 and endostatin in hypertensive diabetic patients with nephropathy: a randomized trial. Hormone and Metabolic Research. 2021;53:470\u20137.","journal-title":"Hormone and Metabolic Research"},{"key":"2228_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1112363","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Huang Q, Zhao D, Lian F, Li X, Qi W. The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications. Frontiers in endocrinology. 2023;14:1112363.","journal-title":"Frontiers in endocrinology"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02228-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02228-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02228-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:03:23Z","timestamp":1783811003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02228-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02228-7","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current work has been registered in PROSPERO registration system with identification number: CRD420251275798. Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}